Cite Filings / SPRO / 0001193125-23-227642

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Spero Therapeutics, Inc. Filed 2023-09-01 Acc 0001193125-23-227642

Documents 1

DEF 14A Proxy Statement , d502179ddef14a.htm

Around this filing

2024-04-16 DEF 14A Proxy Statement
2023-09-01 ARS Annual Report to Security Holders
2023-09-01 DEF 14A Proxy Statement
2023-08-30 4 Chief Development Officer sold 1,854 shares at $1.26 ($2,336)
2023-08-30 4 Chief Legal Officer sold 1,854 shares at $1.26 ($2,336)
2023-08-30 4 Director sold 9,040 shares at $1.26 ($11,390)
2022-08-05 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d502179ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…